David W. Carley

Technik-/Wissenschafts-/F&E-Leiter bei Pier Pharmaceuticals, Inc.

Health Technology

Consumer Services

Finance

Aktive Positionen von David W. Carley

Unternehmen	Position	Beginn	Ende
Pier Pharmaceuticals, Inc. Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO.	Direktor/Vorstandsmitglied	29.06.2011	-
	Technik-/Wissenschafts-/F&E-Leiter	29.06.2011	-
University of Illinois	Corporate Officer/Principal	29.06.2011	-

Unternehmen	Position	Beginn	Ende
RESPIRERX PHARMACEUTICALS INC.	Direktor/Vorstandsmitglied	10.08.2012	-

Massachusetts Institute of Technology	Graduate Degree
Harvard University	Doctorate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
RESPIRERX PHARMACEUTICALS INC.	Health Technology

Private Unternehmen	1
Pier Pharmaceuticals, Inc. Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO.	Health Technology

Private Unternehmen

Health Technology